EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification

Shrea Roy, Jamie Kane iD, Irina Grigorieva, Dylan Roche-Dugmore iD, Sacha Moore iD, Robert Steadman, Anne-Catherine Raby iD, Lily Jakulj, Leon Schurgers iD, Esther Lutgens, Etto C Eringa iD, Marc Vervloet iD und 2 weitere

Biomolecules · 15.05.2026 · 16 (5) · 729

DOI: 10.3390/biom16050729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 15.05.2026. Verfasst von Shrea Roy und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Cell Differentiation, Vascular Calcification, Osteogenesis. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK, IMPROVE-PD (Marie Sklodowska-Curie ITN), Kidney Research UK, Kidney Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular calcification is a strong predictor of cardiovascular mortality and lacks effective treatment. The transformation of vascular smooth muscle cells (VSMCs) into osteoblast-like phenotypes is a key driver of calcification. This study identifies a regulatory role for Hyaluronan (HA) in VSMC osteogenic differentiation and arterial calcification. Human aortic VSMCs stimulated with high phosphate and/or pro-inflammatory cytokines (IL6 and TGF-β1) exhibited increased RUNX2, alkaline phosphatase and osteopontin expression, along with reduced contractility and elevated calcium deposition. This corresponded with reduced HA deposition and downregulation of HA synthase enzymes (HAS1, HAS2), Hyaluronidase enzymes (Hyal1), and HA binding proteins (CD44, TSG-6), whilst HAS3 and versican were upregulated. Comparable alterations in HA and protein expression were observed in an in vivo model of arterial calcification using vitamin K-deficient warfarin-fed mice. Pharmacological inhibition of HA synthesis, enzyme-mediated HA degradation and siRNA/plasmid modulation of HAS isoenzymes demonstrated a possible functional link between HA regulation and VSMC osteogenic differentiation. This study establishes HA and its associated binding proteins as key regulators of arterial calcification, highlighting a novel pathway for potential therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, Smooth, VascularCell DifferentiationVascular CalcificationOsteogenesisHyaluronic AcidMyocytes, Smooth MuscleHumansAnimalsMiceWarfarinCells, Cultured

Stichwörter der Autor:innen

Hyaluronanglycosaminoglycanvascular calcificationvascular smooth muscle cells

Substanzen

Hyaluronic AcidWarfarin

Autor:innen und Institutionen

  • Wales Kidney Research Unit, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
  • Vascular and Interventional Radiology Translational Laboratory, Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Nephrology, Amsterdam University Medical Center, 1081 HV Amsterdam, The Netherlands.
  • Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Unversiteitssingel 50, 6229 ER Maastricht, The Netherlands.
  • Department of Cardiovascular Medicine and Immunology, Mayo Clinic, Rochester, MN 55905, USA.
  • Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, 1081 HV Amsterdam, The Netherlands.

ORCID-Profile: Jamie Kane, Dylan Roche-Dugmore, Sacha Moore, Anne-Catherine Raby, Leon Schurgers, Etto C Eringa, Marc Vervloet, Donald Fraser

Förderung

  • Kidney Research UK
  • IMPROVE-PD (Marie Sklodowska-Curie ITN)
  • Kidney Research UK, Kidney Wales
  • European Union Horizon 2020 project IMPROVE-PD
  • Wellcome Trust-funded GW4-CAT HP Doctoral Fellowship

Zitieren

APA

Roy, S., Kane, J., Grigorieva, I., Roche-Dugmore, D., Moore, S., Steadman, R., Raby, A. C., Jakulj, L., Schurgers, L., Lutgens, E., Eringa, E. C., Vervloet, M., Fraser, D., & Meran, S. (2026). Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification. Biomolecules, 16(5), 729. https://doi.org/10.3390/biom16050729

Vancouver

Roy S, Kane J, Grigorieva I, Roche-Dugmore D, Moore S, Steadman R, et al. Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification. Biomolecules. 2026;16(5):729. doi:10.3390/biom16050729

BibTeX
@article{Roy2026,
  author = {Roy, Shrea and Kane, Jamie and Grigorieva, Irina and Roche-Dugmore, Dylan and Moore, Sacha and Steadman, Robert and Raby, Anne-Catherine and Jakulj, Lily and Schurgers, Leon and Lutgens, Esther and Eringa, Etto C and Vervloet, Marc and Fraser, Donald and Meran, Soma},
  title = {Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {729},
  doi = {10.3390/biom16050729}
}
Kostenlos starten →